Trial Profile
A Prospective Multicenter Phase II Study of Consolidation with Cyclophosphamide, Bortezomib, and Dexamethasone (CVD) in Patients with Multiple Myeloma after Autologous Stem Cell Transplantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2016
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide (Primary) ; Dexamethasone (Primary) ; Dexamethasone (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 06 Sep 2016 New trial record